Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Severe dengue in children associates with dysregulation of lipid homeostasis, complement cascade and retinol transport. | Clin Transl Med | 2023 | 37254651 | PubTator, text mining | PubMed |
| A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis. | Allergy Asthma Clin Immunol | 2023 | 37248521 | PubTator, text mining | PubMed |
| Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients. | Pathol Res Pract | 2023 | 37244049 | PubTator, text mining | PubMed |
| RNA-Seq Analysis Reveals an Essential Role of the cGMP-PKG-MAPK Pathways in Retinal Degeneration Caused by Cep250 Deficiency. | Int J Mol Sci | 2023 | 37240188 | PubTator, text mining | PubMed |
| Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease. | Int J Mol Sci | 2023 | 37240105 | PubTator, text mining | PubMed |
| Current challenges and future opportunities in patient-focused management of hereditary angioedema: A narrative review. | Clin Transl Allergy | 2023 | 37227422 | PubTator, text mining | PubMed |
| Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema. | J Comp Eff Res | 2023 | 37218553 | PubTator, text mining | PubMed |
| Determination of optimum intensity and duration of exercise based on the immune system response using a machine-learning model. | Sci Rep | 2023 | 37217586 | PubTator, text mining | PubMed |
| Losartan-Induced Angioedema: A Case Report. | Cureus | 2023 | 37213987 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity. | EJHaem | 2023 | 37206290 | PubTator, text mining | PubMed |
| Plasma proteome perturbation for CMV DNAemia in kidney transplantation. | PLoS One | 2023 | 37205661 | PubTator, text mining | PubMed |
| Profiling of idiopathic macular hole vitreous proteome identifies the role of extracellular matrix remodelling, epithelial-mesenchymal transformation and unfolded protein-response pathways. | Indian J Ophthalmol | 2023 | 37203077 | PubTator, text mining | PubMed |
| Hereditary angioedema with an acute attack resolved after bone marrow transplantation for acute myeloid leukemia: a case report. | Allergy Asthma Clin Immunol | 2023 | 37194078 | PubTator, text mining | PubMed |
| Large-Scale Integration of Single-Cell RNA-Seq Data Reveals Astrocyte Diversity and Transcriptomic Modules across Six Central Nervous System Disorders. | Biomolecules | 2023 | 37189441 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know. | Immunobiology | 2023 | 37187043 | PubTator, text mining | PubMed |
| HMGB1 cleavage by complement C1s and its potent anti-inflammatory product. | Front Immunol | 2023 | 37180096 | PubTator, text mining | PubMed |
| Editorial: Kinin 2022 Meeting, Annecy, France. | J Clin Med | 2023 | 37176717 | PubTator, text mining | PubMed |
| CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering. | Int J Mol Sci | 2023 | 37175850 | PubTator, text mining | PubMed |
| TXNIP contributes to induction of pro-inflammatory phenotype and caspase-3 activation in astrocytes during Alzheimer's diseases. | Redox Biol | 2023 | 37172394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=28